A survey on risk-based predictive stability tools reveals how pharma companies are leveraging advanced stability approaches throughout the drug development process.
David Hahn
Advertisement
Genentech, Inc., A Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080, USA
Articles by David Hahn
Advertisement
Latest Updated Articles
Risk-Based Predictive Stability–An Industry PerspectivePublished: March 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
2
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
3
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
4
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
5
